0027

COM:KUIHUAYAOYE

葵花药业集团

  • Stock

Last Close

20.69

22/11 07:04

Market Cap

14.25B

Beta: -

Volume Today

8.76M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
338.53M
-
348.84M
3.05%
443.72M
27.20%
592.53M
33.54%
722.77M
21.98%
805.60M
11.46%
739.35M
8.22%
613.36M
17.04%
635.90M
3.68%
670.86M
5.50%
752.63M
12.19%
average payables
213.17M
-
228.31M
7.10%
281.77M
23.41%
339.50M
20.49%
374.63M
10.35%
420.31M
12.19%
485.89M
15.60%
488.43M
0.52%
497.53M
1.86%
630.83M
26.79%
724.54M
14.85%
average receivables
248.85M
-
347.58M
39.67%
477.42M
37.36%
611.02M
27.98%
647.24M
5.93%
685.35M
5.89%
744.54M
8.64%
574.91M
22.78%
392.67M
31.70%
373.39M
4.91%
271.36M
27.32%
book value per share
1.89
-
5.08
168.66%
4.19
17.42%
4.53
7.92%
5.15
13.85%
5.58
8.25%
5.53
0.84%
5.44
1.62%
6.37
17.05%
7.18
12.67%
8.16
13.66%
capex per share
-0.44
-
-0.45
2.10%
-0.30
32.98%
-0.27
9.86%
-0.27
1.31%
-0.55
102.46%
-0.64
17.40%
-0.36
43.31%
-0.20
44.19%
-0.26
28.46%
-0.26
2.12%
capex to depreciation
-3.00
-
-2.72
9.31%
-1.94
28.64%
-1.18
38.98%
-1.09
8.21%
-2.22
104.61%
-2.50
12.52%
-1.43
43.01%
-0.71
50.56%
-0.57
19.34%
-0.81
43.11%
capex to operating cash flow
-0.66
-
-0.49
26.03%
-1.41
187.37%
-0.47
66.83%
-0.28
39.93%
-0.37
31.93%
-0.38
2.95%
-0.18
52.32%
-0.14
24.80%
-0.08
43.26%
-0.16
108.24%
capex to revenue
-0.09
-
-0.07
18.43%
-0.06
19.65%
-0.05
18.85%
-0.04
14.18%
-0.07
76.32%
-0.09
19.31%
-0.06
28.22%
-0.03
56.84%
-0.03
13.16%
-0.03
11.75%
cash per share
1.01
-
4.12
310.12%
1.66
59.73%
1.55
6.90%
1.60
3.36%
2.09
30.64%
2.87
37.37%
3.08
7.35%
3.41
10.97%
6.57
92.29%
6.17
6.06%
days of inventory on hand
161.10
-
123.93
23.07%
145.25
17.20%
168.92
16.30%
186.83
10.60%
162.31
13.13%
133.88
17.51%
141.58
5.75%
142.55
0.68%
107.18
24.81%
124.76
16.40%
days payables outstanding
102.49
-
83.34
18.68%
88.67
6.39%
91.54
3.24%
93.25
1.86%
88.28
5.33%
106.57
20.72%
112.80
5.85%
109.91
2.56%
121.16
10.23%
104.96
13.37%
days sales outstanding
48.57
-
54.37
11.95%
66.13
21.64%
72.94
10.29%
58.92
19.22%
61.09
3.68%
61.85
1.24%
43.14
30.25%
30.78
28.64%
26.55
13.75%
11.16
57.97%
debt to assets
0.33
-
0.20
38.72%
0.05
72.79%
0.08
44.46%
0.02
71.26%
0.04
72.39%
0.08
106.91%
0.06
24.38%
0.04
28.67%
0.06
43.18%
0.00
92.96%
debt to equity
0.82
-
0.34
59.26%
0.08
75.17%
0.13
50.50%
0.03
73.20%
0.06
78.41%
0.13
120.43%
0.10
26.17%
0.07
32.60%
0.10
57.62%
0.01
93.91%
dividend yield
0.04
-
0.04
1.04%
0.01
85.46%
0.01
99.31%
0.01
40.43%
0.04
190.60%
0.07
67.13%
0.07
0.86%
0.02
68.05%
0.03
38.62%
0.04
26.43%
earnings yield
0.05
-
0.05
4.55%
0.02
53.77%
0.03
39.97%
0.06
90.50%
0.08
33.72%
0.07
16.43%
0.07
3.73%
0.07
7.84%
0.06
13.15%
0.07
15.53%
enterprise value
6.01B
-
5.26B
12.46%
13.14B
149.84%
9.24B
29.65%
6.38B
30.98%
6.13B
3.88%
7.56B
23.39%
7.24B
4.33%
8.51B
17.61%
11.62B
36.53%
12.92B
11.15%
enterprise value over ebitda
12.67
-
10.07
20.57%
25.58
154.08%
15.73
38.51%
8.83
43.83%
7.16
19.01%
7.80
9.06%
7.54
3.43%
7.85
4.17%
8.38
6.73%
9.46
12.94%
ev to operating cash flow
20.48
-
13.04
36.32%
104.38
700.55%
27.08
74.06%
11.41
57.85%
7.08
37.99%
7.71
8.91%
6.19
19.75%
9.84
59.02%
5.90
40.06%
13.99
137.26%
ev to sales
2.75
-
1.93
29.78%
4.33
123.82%
2.75
36.53%
1.65
39.78%
1.37
17.13%
1.73
26.22%
2.09
20.80%
1.91
8.73%
2.28
19.55%
2.29
0.55%
free cash flow per share
0.23
-
0.47
108.65%
-0.09
118.72%
0.31
453.84%
0.69
121.86%
0.93
34.32%
1.04
12.06%
1.64
57.24%
1.28
21.69%
3.10
141.93%
1.33
57.27%
free cash flow yield
0.02
-
0.03
89.69%
-0.00
111.37%
0.02
600.04%
0.06
201.06%
0.08
36.58%
0.07
7.32%
0.11
58.21%
0.08
30.21%
0.13
71.79%
0.05
61.88%
graham net net
-0.91
-
1.89
308.08%
0.85
55.07%
0.53
37.41%
0.83
56.92%
0.97
16.59%
1.16
19.80%
1.14
2.51%
1.59
39.96%
3.15
98.47%
4.51
42.91%
graham number
5.05
-
8.88
75.77%
7.04
20.73%
7.28
3.39%
9.20
26.42%
10.98
19.31%
10.99
0.10%
11.06
0.71%
13.17
19.01%
15.46
17.40%
18.75
21.31%
income quality
1.04
-
1.22
17.30%
0.38
68.45%
1.01
161.79%
1.19
18.23%
1.43
19.84%
1.55
8.42%
1.89
22.13%
1.13
39.86%
2.17
90.88%
0.83
61.92%
intangibles to total assets
0.11
-
0.06
44.88%
0.11
91.71%
0.10
10.34%
0.11
9.06%
0.11
0.10%
0.10
6.48%
0.09
9.33%
0.08
16.78%
0.07
17.54%
0.06
2.54%
interest coverage
7.94
-
11.51
45.04%
18.44
60.19%
28.99
57.16%
50.57
74.44%
110.22
117.97%
62.65
43.16%
103.69
65.49%
86.91
16.18%
111.55
28.36%
186.36
67.06%
interest debt per share
1.65
-
1.78
8.21%
0.38
78.60%
0.59
54.29%
0.19
67.33%
0.35
79.89%
0.75
117.60%
0.54
27.70%
0.44
19.73%
0.76
74.28%
0.06
91.81%
inventory turnover
2.27
-
2.95
29.99%
2.51
14.68%
2.16
14.01%
1.95
9.59%
2.25
15.11%
2.73
21.23%
2.58
5.44%
2.56
0.67%
3.41
32.99%
2.93
14.09%
invested capital
0.82
-
0.34
59.26%
0.08
75.17%
0.13
50.50%
0.03
73.20%
0.06
78.41%
0.13
120.43%
0.10
26.17%
0.07
32.60%
0.10
57.62%
0.01
93.91%
market cap
5.76B
-
6.31B
9.55%
13.90B
120.22%
9.82B
29.39%
7.21B
26.55%
7.16B
0.65%
8.60B
20.11%
8.57B
0.35%
9.59B
11.81%
13.58B
41.67%
15.17B
11.71%
net current asset value
-143.97M
-
1.10B
865.81%
909.47M
17.51%
1.08B
19.11%
1.32B
21.49%
1.43B
8.62%
1.21B
15.12%
1.21B
0.12%
1.69B
39.37%
2.27B
33.98%
3.25B
43.42%
net debt to ebitda
0.51
-
-2.02
492.84%
-1.49
26.13%
-0.98
34.34%
-1.15
17.65%
-1.21
4.56%
-1.07
11.01%
-1.39
29.87%
-0.99
28.73%
-1.42
42.58%
-1.65
16.85%
net income per share
0.60
-
0.69
15.00%
0.52
23.91%
0.52
0.95%
0.73
40.38%
0.96
31.51%
0.97
1.04%
1.00
3.09%
1.21
21.00%
1.48
22.31%
1.92
29.48%
operating cash flow per share
0.67
-
0.92
38.03%
0.22
76.68%
0.59
171.76%
0.96
64.29%
1.48
53.45%
1.68
14.04%
2.00
18.90%
1.49
25.78%
3.36
126.41%
1.58
53.00%
payables turnover
3.56
-
4.38
22.98%
4.12
6.01%
3.99
3.14%
3.91
1.83%
4.13
5.63%
3.42
17.16%
3.24
5.52%
3.32
2.63%
3.01
9.28%
3.48
15.43%
receivables turnover
7.52
-
6.71
10.67%
5.52
17.79%
5.00
9.33%
6.19
23.80%
5.98
3.55%
5.90
1.23%
8.46
43.38%
11.86
40.13%
13.75
15.95%
32.71
137.94%
research and ddevelopement to revenue
0.01
-
0.01
29.96%
0.01
58.00%
0.02
46.90%
0.03
40.21%
0.03
1.30%
0.03
0.85%
0.03
23.89%
0.03
9.46%
0.02
35.12%
0.02
3.88%
return on tangible assets
0.14
-
0.09
38.95%
0.09
7.22%
0.08
13.07%
0.11
33.60%
0.13
17.37%
0.12
5.12%
0.13
6.17%
0.14
7.52%
0.13
2.85%
0.17
31.63%
revenue per share
4.98
-
6.23
25.18%
5.20
16.59%
5.77
11.08%
6.64
14.99%
7.62
14.82%
7.50
1.60%
5.92
21.02%
7.66
29.31%
8.69
13.52%
9.64
10.91%
roe
0.32
-
0.14
57.20%
0.13
7.86%
0.11
8.23%
0.14
23.31%
0.17
21.48%
0.18
1.90%
0.18
4.79%
0.19
3.38%
0.21
8.55%
0.23
13.92%
roic
0.17
-
0.11
36.49%
0.10
0.55%
0.09
11.40%
0.15
60.78%
0.17
16.60%
0.17
2.30%
0.18
4.41%
0.19
7.29%
0.20
3.04%
0.21
8.02%
sales general and administrative to revenue
0.02
-
0.02
1.63%
0.03
32.32%
0.03
21.68%
0.03
11.21%
0.03
14.86%
0.03
1.04%
0.02
9.80%
0.03
13.26%
0.03
2.38%
0.08
227.21%
shareholders equity per share
1.89
-
5.08
168.66%
4.19
17.42%
4.53
7.92%
5.15
13.85%
5.58
8.25%
5.53
0.84%
5.44
1.62%
6.37
17.05%
7.18
12.67%
8.16
13.66%
stock based compensation to revenue
tangible asset value
641.30M
-
2.06B
220.67%
2.18B
5.95%
2.37B
8.78%
2.66B
12.24%
2.87B
7.89%
2.87B
0.11%
2.91B
1.10%
3.49B
20.12%
3.98B
14.06%
4.91B
23.34%
tangible book value per share
1.46
-
4.71
221.99%
3.73
20.82%
4.07
9.02%
4.58
12.61%
4.89
6.80%
4.93
0.77%
4.97
0.83%
5.99
20.54%
6.79
13.38%
8.41
23.75%
working capital
113.53M
-
1.50B
1,222.57%
1.21B
19.14%
1.43B
17.93%
1.67B
16.85%
1.84B
9.83%
1.78B
3.35%
1.78B
0.18%
2.14B
20.29%
2.69B
25.48%
3.27B
21.68%

All numbers in (except ratios and percentages)